Claire Harrison

34.7k citations
452 papers · 15.0k · 6 hit papers · h-index 58

Impact in

  • Genetics top 0.01%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Hemoglobinopathies and Related Disorders
  • Hematology top 0.02%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
    • Platelet Disorders and Treatments

Papers in

    • Myeloproliferative Neoplasms: Diagnosis and Treatment 409
    • Hemoglobinopathies and Related Disorders 34
    • Chronic Myeloid Leukemia Treatments 188
    • Acute Myeloid Leukemia Research 119
    • Multiple Myeloma Research and Treatments 43
    • Platelet Disorders and Treatments 22

Claire Harrison

427 papers receiving 14.7k citations

Claire Harrison's Hit Papers

Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis 2016 · 350 citations
3500+7+14Years since publication4008001.2k

Peers

Claire Harrison
Comparison fields: 5 of 127
  • Genetics 12.8k
  • Hematology 9.4k
  • Rheumatology 5.1k
  • Molecular Biology 7.7k
  • Oncology 1.2k
Replace Francesco Passamonti with:
Francesco Passamonti Italy
Jean‐Jacques Kiladjian France
Francisco Cervantes Spain
Alessandro M. Vannucchi Italy
Martha Wadleigh United States
Mary Frances McMullin United Kingdom
John Mascarenhas United States
Suzanne R. Hayman United States
Sigurður Y. Kristinsson Sweden
Gabriel Étienne France
Claire Harrison relative to Francesco Passamonti Italy Francesco Passamonti's profile →
Citations per field
00.5×1.5×
Francesco Passamonti · 1×
Citations per year

Countries citing papers authored by Claire Harrison

Since Specialization
Citations

This map shows the geographic impact of Claire Harrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Harrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Harrison more than expected).

Fields of papers citing papers by Claire Harrison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Harrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Harrison. The network helps show where Claire Harrison may publish in the future.

Co-authors

The 25 scholars most cited alongside Claire Harrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Claire Harrison Line = papers co-authored together Claire Harrison links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 452 papers — load more, or switch the sort, to bring in the rest.

#Work
1
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
Hit paper breakdown →
20121218
2
JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis
Hit paper breakdown →
2007898
3
Hydroxyurea Compared with Anagrelide in High-Risk Essential Thrombocythemia
Hit paper breakdown →
2005610
4
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera
Hit paper breakdown →
2015594
5 2005473
6
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
Hit paper breakdown →
2016350
7
Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis
Hit paper breakdown →
2015340
8 2013294
9 2008290
10 2018255
11 2006252
12 2013239
13 2011230
14 2005228
15 2017222
16 2017221
17 2017212
18 2006212
19 2009212
20 2010204

About Claire Harrison

Claire Harrison is a scholar working on Genetics, Hematology, Molecular Biology, Rheumatology and Oncology, having authored 452 papers that have together received 15.0k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (409 papers), Chronic Myeloid Leukemia Treatments (188 papers), Kruppel-like factors research (144 papers), Acute Myeloid Leukemia Research (119 papers), Eosinophilic Disorders and Syndromes (108 papers), Multiple Myeloma Research and Treatments (43 papers), Hemoglobinopathies and Related Disorders (34 papers) and Platelet Disorders and Treatments (22 papers). The work is most often cited by research in Genetics (12.8k citations), Hematology (9.4k citations), Rheumatology (5.1k citations), Molecular Biology (7.7k citations) and Oncology (1.2k citations). Claire Harrison has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Anthony R. Green, Ruben A. Mesa, Francisco Cervantes, Tiziano Barbui, Mary Frances McMullin, Francesco Passamonti, Srđan Verstovšek and Peter J. Campbell. Their work appears in journals such as Blood, British Journal of Haematology, HemaSphere, Journal of Clinical Oncology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact